Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Steinbach, JP; Supra, P; Huang, HJS; Cavenee, WK; Weller, M
   CD95-mediated apoptosis of human glioma cells: Modulation by epidermal growth factor receptor activity
   BRAIN PATHOLOGY
   
   J.P. Steinbach et al., "CD95-mediated apoptosis of human glioma cells: Modulation by epidermal growth factor receptor activity", BRAIN PATH, 12(1), 2002, pp. 12-20
2. Fuller, GN; Hess, KR; Rhee, CH; Yung, WKA; Sawaya, RA; Bruner, JM; Zhang, W
   Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets
   BRAIN PATHOLOGY
   
   G.N. Fuller et al., "Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets", BRAIN PATH, 12(1), 2002, pp. 108-116
3. Begemann, M; Fuller, GN; Holland, EC
   Genetic modeling of glioma formation in mice
   BRAIN PATHOLOGY
   
   M. Begemann et al., "Genetic modeling of glioma formation in mice", BRAIN PATH, 12(1), 2002, pp. 117-132
4. Herfarth, KK; Gutwein, S; Debus, J
   Postoperative radiotherapy of astrocytomas
   SEMINARS IN SURGICAL ONCOLOGY
   
   K.K. Herfarth et al., "Postoperative radiotherapy of astrocytomas", SEM SURG ON, 20(1), 2001, pp. 13-23
5. Funakoshi, M; Sonoda, Y; Tago, K; Tominaga, S; Kasahara, T
   Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-kappa B and AP-1 activation
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   M. Funakoshi et al., "Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-kappa B and AP-1 activation", INT IMMUNO, 1(3), 2001, pp. 595-604
6. Hirose, Y; Aldape, K; Takahashi, M; Berger, MS; Feuerstein, BG
   Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors
   JOURNAL OF MOLECULAR DIAGNOSTICS
   
   Y. Hirose et al., "Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors", J MOL DIAGN, 3(2), 2001, pp. 62-67
7. Atencio, IA; Avanzini, JB; Johnson, D; Neuteboom, S; Vaillancourt, MT; Nielsen, LL; Hajian, G; Sutjipto, S; Sugarman, BJ; Philopena, J; McAllister, DL; Beltran, JC; Nodelman, M; Ramachandra, M; Wills, KN
   Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
   MOLECULAR THERAPY
   
   I.A. Atencio et al., "Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment", MOL THER, 4(1), 2001, pp. 5-12
8. Gururangan, S; Cokgor, I; Rich, JN; Edwards, S; Affronti, ML; Quinn, JA; Herndon, JE; Provenzale, JM; McLendon, RE; Tourt-Uhlig, S; Sampson, JH; Stafford-Fox, V; Zaknoen, S; Early, M; Friedman, AH; Friedman, HS
   Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
   NEURO-ONCOLOGY
   
   S. Gururangan et al., "Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas", NEURO-ONCOL, 3(4), 2001, pp. 246-250
9. Cerrato, JA; Yung, WKA; Liu, TJ
   Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis
   NEURO-ONCOLOGY
   
   J.A. Cerrato et al., "Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis", NEURO-ONCOL, 3(2), 2001, pp. 113-122
10. Dillman, RO; Shea, WM; Tai, DF; Mahdavi, K; Barth, NM; Kharkar, BR; Poor, MM; Church, CK; DePriest, C
    Interferon-alpha 2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma
    NEURO-ONCOLOGY
    
    R.O. Dillman et al., "Interferon-alpha 2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma", NEURO-ONCOL, 3(1), 2001, pp. 35-41
11. Kragh, M; Quistorff, B; Lund, EL; Kristjansen, PEG
    Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy
    NEOPLASIA
    
    M. Kragh et al., "Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy", NEOPLASIA, 3(4), 2001, pp. 324-330
12. de Fraipont, F; Nicholson, AC; Feige, JJ; Van Meir, EG
    Thrombospondins and tumor angiogenesis
    TRENDS IN MOLECULAR MEDICINE
    
    F. de Fraipont et al., "Thrombospondins and tumor angiogenesis", TRENDS MO M, 7(9), 2001, pp. 401-407
13. Alavi, JB; Eck, SL
    Gene therapy for high grade gliomas
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    J.B. Alavi e S.L. Eck, "Gene therapy for high grade gliomas", EXPERT OP B, 1(2), 2001, pp. 239-252
14. Jain, KK
    Use of bacteria as anticancer agents
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    K.K. Jain, "Use of bacteria as anticancer agents", EXPERT OP B, 1(2), 2001, pp. 291-300
15. Holland, EC
    Gliomagenesis: Genetic alterations and mouse models
    NATURE REVIEWS GENETICS
    
    E.C. Holland, "Gliomagenesis: Genetic alterations and mouse models", NAT REV GEN, 2(2), 2001, pp. 120-129
16. Ly, A; Duc, HT; Kalamarides, M; Trojan, LA; Pan, Y; Shevelev, A; Francois, JC; Noel, T; Kane, A; Henin, D; Anthony, DD; Trojan, J
    Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapyof glioblastoma
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    A. Ly et al., "Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapyof glioblastoma", J CL PATH-M, 54(4), 2001, pp. 230-239
17. Rubenstein, M; Glick, R; Lichtor, T; Mirochnik, Y; Chou, P; Guinan, P
    Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding - Transforming growth factor-alpha and theepidermal growth factor receptor
    MEDICAL ONCOLOGY
    
    M. Rubenstein et al., "Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding - Transforming growth factor-alpha and theepidermal growth factor receptor", MED ONCOL, 18(2), 2001, pp. 121-130
18. Kuan, CT; Wikstrand, CJ; Bigner, DD
    EGF mutant receptor vIII as a molecular target in cancer therapy
    ENDOCRINE-RELATED CANCER
    
    C.T. Kuan et al., "EGF mutant receptor vIII as a molecular target in cancer therapy", ENDOCR-R CA, 8(2), 2001, pp. 83-96
19. Matulic, M; Brdar, B
    Induction of urokinase-type plasminogen activator by sodium salicylate in a glioblastoma cell strain
    FOOD TECHNOLOGY AND BIOTECHNOLOGY
    
    M. Matulic e B. Brdar, "Induction of urokinase-type plasminogen activator by sodium salicylate in a glioblastoma cell strain", FOOD TECH B, 39(1), 2001, pp. 5-11
20. Horiguchi, H; Sano, T; Hirose, T
    TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization
    PATHOLOGY INTERNATIONAL
    
    H. Horiguchi et al., "TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization", PATHOL INT, 51(3), 2001, pp. 187-192
21. Jennings, MT; Iyengar, S
    Pharmacotherapy of malignant astrocytomas of children and adults - Currentstrategies and future trends
    CNS DRUGS
    
    M.T. Jennings e S. Iyengar, "Pharmacotherapy of malignant astrocytomas of children and adults - Currentstrategies and future trends", CNS DRUGS, 15(9), 2001, pp. 719-743
22. Hess, KR; Fuller, GN; Rhee, CH; Zhang, W
    Statistical pattern analysis of gene expression profiles for glioblastoma tissues and cell lines
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    K.R. Hess et al., "Statistical pattern analysis of gene expression profiles for glioblastoma tissues and cell lines", INT J MOL M, 8(2), 2001, pp. 183-188
23. Huehne, K; Rautenstrauss, B
    Transcriptional startpoints and methylation patterns in the PMP22 promoters of peripheral nerve, leukocytes and tumor cell lines
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    K. Huehne e B. Rautenstrauss, "Transcriptional startpoints and methylation patterns in the PMP22 promoters of peripheral nerve, leukocytes and tumor cell lines", INT J MOL M, 7(6), 2001, pp. 669-675
24. Friend, KE; Khandwala, HM; Flyvbjerg, A; Hill, H; Li, J; McCutcheon, IE
    Growth hormone and insulin-like growth factor-1: effects on the growth of glioma cell lines
    GROWTH HORMONE & IGF RESEARCH
    
    K.E. Friend et al., "Growth hormone and insulin-like growth factor-1: effects on the growth of glioma cell lines", GROWTH H I, 11(2), 2001, pp. 84-91
25. Markert, JM; Fuller, CM; Gillespie, GY; Bubien, JK; McLean, LA; Hong, RL; Lee, K; Gullans, SR; Mapstone, TB; Benos, DJ
    Differential gene expression profiling in human brain tumors
    PHYSIOLOGICAL GENOMICS
    
    J.M. Markert et al., "Differential gene expression profiling in human brain tumors", PHYSIOL GEN, 5(1), 2001, pp. 21-33
26. Ammirati, M; Rao, S; Granger, G
    Detection of tnf inhibithors (soluble receptors) in the sera and tumor cyst fluid of patients with malignant astrocytomas of the brain
    FRONTIERS IN BIOSCIENCE
    
    M. Ammirati et al., "Detection of tnf inhibithors (soluble receptors) in the sera and tumor cyst fluid of patients with malignant astrocytomas of the brain", FRONT BIOSC, 6, 2001, pp. B17-B24
27. Squire, JA; Arab, S; Marrano, P; Bayani, J; Karaskova, J; Taylor, M; Becker, L; Rutka, J; Zielenska, M
    Molecular cytogenetic analysis of glial tumors using spectral karyotyping and comparative genomic hybridization
    MOLECULAR DIAGNOSIS
    
    J.A. Squire et al., "Molecular cytogenetic analysis of glial tumors using spectral karyotyping and comparative genomic hybridization", MOL DIAGN, 6(2), 2001, pp. 93-108
28. Xiong, QH; Shi, Q; Le, XD; Wang, BL; Xie, KP
    Regulation of interleukin-8 expression by nitric oxide in human pancreaticadenocarcinoma
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    Q.H. Xiong et al., "Regulation of interleukin-8 expression by nitric oxide in human pancreaticadenocarcinoma", J INTERF CY, 21(7), 2001, pp. 529-537
29. Beresford, SA; Davies, MA; Gallick, GE; Donato, NJ
    Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PC-3 prostate cancer cells
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    S.A. Beresford et al., "Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PC-3 prostate cancer cells", J INTERF CY, 21(5), 2001, pp. 313-322
30. Calogero, A; Arcella, A; De Gregorio, G; Porcellini, A; Mercola, D; Liu, CT; Lombari, V; Zani, M; Giannini, G; Gagliardi, FM; Caruso, R; Gulino, A; Frati, L; Ragona, G
    The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas
    CLINICAL CANCER RESEARCH
    
    A. Calogero et al., "The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas", CLIN CANC R, 7(9), 2001, pp. 2788-2796
31. Reiss, K; Tu, X; Romano, G; Peruzzi, F; Wang, JY; Baserga, R
    Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors
    CLINICAL CANCER RESEARCH
    
    K. Reiss et al., "Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors", CLIN CANC R, 7(7), 2001, pp. 2134-2144
32. Bhattacharya, A; Lakka, SS; Mohanam, S; Boyd, D; Rao, JS
    Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines
    CLINICAL CANCER RESEARCH
    
    A. Bhattacharya et al., "Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines", CLIN CANC R, 7(2), 2001, pp. 267-276
33. Xu, G; McLeod, HL
    Strategies for enzyme/prodrug cancer therapy
    CLINICAL CANCER RESEARCH
    
    G. Xu e H.L. McLeod, "Strategies for enzyme/prodrug cancer therapy", CLIN CANC R, 7(11), 2001, pp. 3314-3324
34. Suzuki, A; Yamaguchi, MT; Ohteki, T; Sasaki, T; Kaisho, T; Kimura, Y; Yoshida, R; Wakeham, A; Higuchi, T; Fukumoto, M; Tsubata, T; Ohashi, PS; Koyasu, S; Penninger, JM; Nakano, T; Mak, TW
    T cell-specific loss of Pten leads to defects in central and peripheral tolerance
    IMMUNITY
    
    A. Suzuki et al., "T cell-specific loss of Pten leads to defects in central and peripheral tolerance", IMMUNITY, 14(5), 2001, pp. 523-534
35. Maggard, M; Meng, LZ; Ke, BB; Allen, R; Devgan, L; Imagawa, DK
    Antisense TGF-beta 2 immunotherapy for hepatocellular carcinoma: Treatmentin a rat tumor model
    ANNALS OF SURGICAL ONCOLOGY
    
    M. Maggard et al., "Antisense TGF-beta 2 immunotherapy for hepatocellular carcinoma: Treatmentin a rat tumor model", ANN SURG O, 8(1), 2001, pp. 32-37
36. Tews, DS; Fleissner, C; Tiziani, B; Gaumann, AKA
    Intrinsic expression of drug resistance-associated factors in meningiomas
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    D.S. Tews et al., "Intrinsic expression of drug resistance-associated factors in meningiomas", APPL IMMUNO, 9(3), 2001, pp. 242-249
37. Platten, M; Wick, W; Weller, M
    Malignant glioma biology: Role for TGF-beta in growth, motility, angiogenesis, and immune escape
    MICROSCOPY RESEARCH AND TECHNIQUE
    
    M. Platten et al., "Malignant glioma biology: Role for TGF-beta in growth, motility, angiogenesis, and immune escape", MICROSC RES, 52(4), 2001, pp. 401-410
38. Bauman, GS; Cairncross, JG
    Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas
    SEMINARS IN RADIATION ONCOLOGY
    
    G.S. Bauman e J.G. Cairncross, "Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas", SEM RAD ONC, 11(2), 2001, pp. 170-180
39. McKnight, TR; Noworolski, SM; Vigneron, DB; Nelson, SJ
    An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma
    JOURNAL OF MAGNETIC RESONANCE IMAGING
    
    T.R. McKnight et al., "An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma", J MAGN R I, 13(2), 2001, pp. 167-177
40. Kubota, H; Nishizaki, T; Harada, K; Harada, K; Oga, A; Ito, H; Suzuki, M; Sasaki, K
    Identification of recurrent chromosomal rearrangements and the unique relationship between low-level amplification and translocation in gliablastoma
    GENES CHROMOSOMES & CANCER
    
    H. Kubota et al., "Identification of recurrent chromosomal rearrangements and the unique relationship between low-level amplification and translocation in gliablastoma", GENE CHROM, 31(2), 2001, pp. 125-133
41. Warr, T; Ward, S; Burrows, L; Harding, B; Wilkins, P; Harkness, W; Hayward, R; Darling, J; Thomas, D
    Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults
    GENES CHROMOSOMES & CANCER
    
    T. Warr et al., "Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults", GENE CHROM, 31(1), 2001, pp. 15-22
42. Reilly, KM; Jacks, T
    Genetically engineered mouse models of astrocytoma: GEMs in the rough?
    SEMINARS IN CANCER BIOLOGY
    
    K.M. Reilly e T. Jacks, "Genetically engineered mouse models of astrocytoma: GEMs in the rough?", SEM CANC B, 11(3), 2001, pp. 177-190
43. Lednicky, JA; Butel, JS
    Simian virus 40 regulatory region structural diversity and the associationof viral archetypal regulatory regions with human brain tumors
    SEMINARS IN CANCER BIOLOGY
    
    J.A. Lednicky e J.S. Butel, "Simian virus 40 regulatory region structural diversity and the associationof viral archetypal regulatory regions with human brain tumors", SEM CANC B, 11(1), 2001, pp. 39-47
44. Huang, YW; Hayes, RL; Wertheim, S; Arbit, E; Scheff, R
    Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    Y.W. Huang et al., "Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report", CR R ONC H, 39(1-2), 2001, pp. 17-23
45. Hayes, RL; Arbit, E; Odaimi, M; Pannullo, S; Scheff, R; Kravchinskiy, D; Zaroulis, C
    Adoptive cellular immunotherapy for the treatment of malignant gliomas
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    R.L. Hayes et al., "Adoptive cellular immunotherapy for the treatment of malignant gliomas", CR R ONC H, 39(1-2), 2001, pp. 31-42
46. Nash, KT; Thompson, JP; Debinski, W
    Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    K.T. Nash et al., "Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins", CR R ONC H, 39(1-2), 2001, pp. 87-98
47. Hulshof, MCCM; Sminia, P; Barten-Van Rijbroek, AD; Gonzalez, DG
    Prognostic value of plasma: transforming growth factor-beta in patients with glioblastoma multiforme
    ONCOLOGY REPORTS
    
    M.C.C.M. Hulshof et al., "Prognostic value of plasma: transforming growth factor-beta in patients with glioblastoma multiforme", ONCOL REP, 8(5), 2001, pp. 1107-1110
48. Nemoto, K; Ogawa, Y; Matsushita, H; Takeda, K; Takahashi, C; Fujimoto, K; Nomiya, T; Saito, H; Takai, Y; Yamada, S
    Radiation therapy with uneven fractionation for malignant gliomas
    ONCOLOGY REPORTS
    
    K. Nemoto et al., "Radiation therapy with uneven fractionation for malignant gliomas", ONCOL REP, 8(1), 2001, pp. 103-106
49. Nirmala, C; Rao, JS; Ruifrok, AC; Langford, LA; Obeyesekere, M
    Growth characteristics of glioblastoma spheroids
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    C. Nirmala et al., "Growth characteristics of glioblastoma spheroids", INT J ONCOL, 19(6), 2001, pp. 1109-1115
50. Kim, IA; Yang, YJ; Yoon, SC; Choi, IB; Kay, CS; Kwon, HC; Kim, CM; Joe, YA; Kang, JK; Hong, YK
    Potential of adenoviral p53 gene therapy and irradiation for the treatmentof malignant gliomas
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    I.A. Kim et al., "Potential of adenoviral p53 gene therapy and irradiation for the treatmentof malignant gliomas", INT J ONCOL, 19(5), 2001, pp. 1041-1047
51. Tasiou, A; Konduri, SD; Yanamandra, N; Dinh, DH; Olivero, WC; Gujrati, M; Obeyesekere, M; Rao, JS
    A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    A. Tasiou et al., "A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas", INT J ONCOL, 19(3), 2001, pp. 591-597
52. Alonso, ME; Bello, MJ; Lomas, J; Gonzalez-Gomez, P; Arjona, D; De Campos, JM; Gutierrez, M; Isla, A; Vaquero, J; Rey, JA
    Absence of mutation of the p73 gene in astrocytic neoplasms
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    M.E. Alonso et al., "Absence of mutation of the p73 gene in astrocytic neoplasms", INT J ONCOL, 19(3), 2001, pp. 609-612
53. Ljubimova, JY; Khazenzon, NM; Chen, ZT; Neyman, YI; Turner, L; Riedinger, MS; Black, KL
    Gene expression abnormalities in human glial tumors identified by gene array
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    J.Y. Ljubimova et al., "Gene expression abnormalities in human glial tumors identified by gene array", INT J ONCOL, 18(2), 2001, pp. 287-295
54. Yoon, KS; Lee, MC; Kang, SS; Kim, JH; Jung, S; Kim, YJ; Lee, JH; Ahn, KY; Lee, JS; Cheon, JY
    p53 mutation and epidermal growth factor receptor overexpression in glioblastoma
    JOURNAL OF KOREAN MEDICAL SCIENCE
    
    K.S. Yoon et al., "p53 mutation and epidermal growth factor receptor overexpression in glioblastoma", J KOR MED S, 16(4), 2001, pp. 481-488
55. Wybranietz, WA; Gross, CD; Phelan, A; O'Hare, P; Spiegel, M; Graepler, F; Bitzer, M; Stahler, P; Gregor, M; Lauer, UM
    Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosinedeaminase (CD) fusion gene
    GENE THERAPY
    
    W.A. Wybranietz et al., "Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosinedeaminase (CD) fusion gene", GENE THER, 8(21), 2001, pp. 1654-1664
56. Lopez-Corcuera, B; Geerlings, A; Aragon, C
    Glycine neurotransmitter transporters: an update
    MOLECULAR MEMBRANE BIOLOGY
    
    B. Lopez-Corcuera et al., "Glycine neurotransmitter transporters: an update", MOL MEMBR B, 18(1), 2001, pp. 13-20
57. Tietze, LF; Bothe, U; Griesbach, U; Nakaichi, M; Hasegawa, T; Nakamura, H; Yamamoto, Y
    ortho-Carboranyl glycosides for the treatment of cancer by boron neutron capture therapy
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    L.F. Tietze et al., "ortho-Carboranyl glycosides for the treatment of cancer by boron neutron capture therapy", BIO MED CH, 9(7), 2001, pp. 1747-1752
58. Weng, LP; Brown, JL; Eng, C
    PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model
    HUMAN MOLECULAR GENETICS
    
    L.P. Weng et al., "PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model", HUM MOL GEN, 10(6), 2001, pp. 599-604
59. Weng, LP; Brown, JL; Eng, C
    PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways
    HUMAN MOLECULAR GENETICS
    
    L.P. Weng et al., "PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways", HUM MOL GEN, 10(3), 2001, pp. 237-242
60. Weng, LP; Gimm, O; Kum, JB; Smith, WM; Zhou, XP; Wynford-Thomas, D; Leone, G; Eng, C
    Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death
    HUMAN MOLECULAR GENETICS
    
    L.P. Weng et al., "Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death", HUM MOL GEN, 10(3), 2001, pp. 251-258
61. Deisboeck, TS; Berens, ME; Kansal, AR; Torquato, S; Stemmer-Rachamimov, AO; Chiocca, EA
    Pattern of self-organization in tumour systems: complex growth dynamics ina novel brain tumour spheroid model
    CELL PROLIFERATION
    
    T.S. Deisboeck et al., "Pattern of self-organization in tumour systems: complex growth dynamics ina novel brain tumour spheroid model", CELL PROLIF, 34(2), 2001, pp. 115-134
62. Kragh, M; Quistorff, B; Kristjansen, PEG
    Quantitative estimates of angiogenic and anti-angiogenic activity by laserDoppler flowmetry (LDF) and near infra-red spectroscopy (NIRS)
    EUROPEAN JOURNAL OF CANCER
    
    M. Kragh et al., "Quantitative estimates of angiogenic and anti-angiogenic activity by laserDoppler flowmetry (LDF) and near infra-red spectroscopy (NIRS)", EUR J CANC, 37(7), 2001, pp. 924-929
63. Brandes, AA; Lacombe, D; Vecht, C
    Future trends in the treatment of brain tumours
    EUROPEAN JOURNAL OF CANCER
    
    A.A. Brandes et al., "Future trends in the treatment of brain tumours", EUR J CANC, 37(18), 2001, pp. 2297-2301
64. Liigant, A; Kulla, A; Linnamagi, U; Asser, T; Kaasik, AE
    Survival of patients with primary CNS tumours in Estonia
    EUROPEAN JOURNAL OF CANCER
    
    A. Liigant et al., "Survival of patients with primary CNS tumours in Estonia", EUR J CANC, 37(15), 2001, pp. 1895-1903
65. Torres, J; Navarro, S; Rogla, I; Ripoll, F; Lluch, A; Garcia-Conde, J; Llombart-Bosch, A; Cervera, J; Pulido, R
    Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues
    EUROPEAN JOURNAL OF CANCER
    
    J. Torres et al., "Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues", EUR J CANC, 37(1), 2001, pp. 114-121
66. Takahashi, A
    Different inducibility of radiation- or heat-induced p53-dependent apoptosis after acute or chronic irradiation in human cultured squamous cell carcinoma cells
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    
    A. Takahashi, "Different inducibility of radiation- or heat-induced p53-dependent apoptosis after acute or chronic irradiation in human cultured squamous cell carcinoma cells", INT J RAD B, 77(2), 2001, pp. 215-224
67. Han, XS; Stewart, JE; Bellis, SL; Benveniste, EN; Ding, Q; Tachibana, K; Grammer, JR; Gladson, CL
    TGF-beta 1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate
    ONCOGENE
    
    X.S. Han et al., "TGF-beta 1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate", ONCOGENE, 20(55), 2001, pp. 7976-7986
68. Stivala, LA; Riva, F; Cazzalini, O; Savio, M; Prosperi, E
    p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excisionrepair downstream the recruitment of PCNA to DNA repair sites
    ONCOGENE
    
    L.A. Stivala et al., "p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excisionrepair downstream the recruitment of PCNA to DNA repair sites", ONCOGENE, 20(5), 2001, pp. 563-570
69. Kucharczak, J; Pannequin, J; Camby, I; Decaestecker, C; Kiss, R; Martinez, J
    Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration
    ONCOGENE
    
    J. Kucharczak et al., "Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration", ONCOGENE, 20(48), 2001, pp. 7021-7028
70. King, JG; Khalili, K
    Inhibition of human brain tumor cell growth by the anti-inflammatory drug,flurbiprofen
    ONCOGENE
    
    J.G. King e K. Khalili, "Inhibition of human brain tumor cell growth by the anti-inflammatory drug,flurbiprofen", ONCOGENE, 20(47), 2001, pp. 6864-6870
71. Konduri, SD; Rao, CN; Chandrasekar, N; Tasiou, A; Mohanam, S; Kin, Y; Lakka, SS; Dinh, D; Olivero, WC; Gujrati, M; Foster, DC; Kisiel, W; Rao, JS
    A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion
    ONCOGENE
    
    S.D. Konduri et al., "A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion", ONCOGENE, 20(47), 2001, pp. 6938-6945
72. Wu, CJ; O'Rourke, DM; Feng, GS; Johnson, GR; Wang, Q; Greene, MI
    The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors
    ONCOGENE
    
    C.J. Wu et al., "The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors", ONCOGENE, 20(42), 2001, pp. 6018-6025
73. Struss, AK; Romeike, BFM; Munnia, A; Nastainczyk, W; Steudel, WI; Konig, J; Ohgaki, H; Feiden, W; Fischer, U; Meese, E
    PHF3-specific antibody responses in over 60% of patients with glioblastomamultiforme
    ONCOGENE
    
    A.K. Struss et al., "PHF3-specific antibody responses in over 60% of patients with glioblastomamultiforme", ONCOGENE, 20(31), 2001, pp. 4107-4114
74. Mohanam, S; Jasti, SL; Kondraganti, SR; Chandrasekar, N; Lakka, SS; Kin, Y; Fuller, GN; Yung, AWK; Kyritsis, AP; Dinh, DH; Olivero, WC; Gujrati, M; Ali-Osman, F; Rao, JS
    Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells
    ONCOGENE
    
    S. Mohanam et al., "Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells", ONCOGENE, 20(28), 2001, pp. 3665-3673
75. Park, JS; Qiao, L; Su, ZZ; Hinman, D; Willoughby, K; McKinstry, R; Yacoub, A; Duigou, GJ; Young, CSH; Grant, S; Hagan, MP; Ellis, E; Fisher, PB; Dent, P
    Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways
    ONCOGENE
    
    J.S. Park et al., "Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways", ONCOGENE, 20(25), 2001, pp. 3266-3280
76. Aichholzer, M; Mazal, PR; Haberler, C; Dietrich, W; Bertalanffy, A; Roessler, K; Ungersboeck, K
    Epidural metastasis of a glioblastoma after stereotactic biopsy: Case report
    MINIMALLY INVASIVE NEUROSURGERY
    
    M. Aichholzer et al., "Epidural metastasis of a glioblastoma after stereotactic biopsy: Case report", MIN IN NEUR, 44(3), 2001, pp. 175-177
77. Lafitte, F; Morel-Precetti, S; Martin-Duverneuil, N; Guermazi, A; Brunet, E; Heran, F; Chiras, J
    Multiple glioblastomas: CT and MR features
    EUROPEAN RADIOLOGY
    
    F. Lafitte et al., "Multiple glioblastomas: CT and MR features", EUR RADIOL, 11(1), 2001, pp. 131-136
78. Rainov, NG; Fels, C; Droge, JW; Schafer, C; Kramm, CM; Chou, TC
    Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma
    CANCER GENE THERAPY
    
    N.G. Rainov et al., "Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma", CANC GENE T, 8(9), 2001, pp. 662-668
79. Glenn, GM; Chatterjee, S
    Generation of adenoviruses encoding the herpes simplex virus vhs gene: A novel strategy to generate adenoviruses expressing genes toxic to producer cells
    CANCER GENE THERAPY
    
    G.M. Glenn e S. Chatterjee, "Generation of adenoviruses encoding the herpes simplex virus vhs gene: A novel strategy to generate adenoviruses expressing genes toxic to producer cells", CANC GENE T, 8(8), 2001, pp. 566-572
80. Maleniak, TC; Darling, JL; Lowenstein, PR; Castro, MG
    Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell deathin primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU
    CANCER GENE THERAPY
    
    T.C. Maleniak et al., "Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell deathin primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU", CANC GENE T, 8(8), 2001, pp. 589-598
81. Spear, MA; Breakefield, XO; Beltzer, J; Schuback, D; Weissleder, R; Pardo, FS; Ladner, R
    Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells
    CANCER GENE THERAPY
    
    M.A. Spear et al., "Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells", CANC GENE T, 8(7), 2001, pp. 506-511
82. McNeish, IA; Tenev, T; Bell, S; Marani, M; Vassaux, G; Lemoine, N
    Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells
    CANCER GENE THERAPY
    
    I.A. McNeish et al., "Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells", CANC GENE T, 8(4), 2001, pp. 308-319
83. Pedersen, MW; Meltorn, M; Damstrup, L; Poulsen, HS
    The type III epidermal growth factor receptor mutation - Biological significance and potential target for anti-cancer therapy
    ANNALS OF ONCOLOGY
    
    M.W. Pedersen et al., "The type III epidermal growth factor receptor mutation - Biological significance and potential target for anti-cancer therapy", ANN ONCOL, 12(6), 2001, pp. 745-760
84. Brada, M; Hoang-Xuan, K; Rampling, R; Dietrich, PY; Dirix, LY; Macdonald, D; Heimans, JJ; Zonnenberg, BA; Bravo-Marques, JM; Henriksson, R; Stupp, R; Yue, N; Bruner, J; Dugan, M; Rao, S; Zaknoen, S
    Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
    ANNALS OF ONCOLOGY
    
    M. Brada et al., "Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse", ANN ONCOL, 12(2), 2001, pp. 259-266
85. Matsuda, S; Kudoh, S; Katayama, S
    Enhanced formation of azoxymethane-induced colorectal adenocarcinoma in gamma delta T lymphocyte-deficient mice
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    S. Matsuda et al., "Enhanced formation of azoxymethane-induced colorectal adenocarcinoma in gamma delta T lymphocyte-deficient mice", JPN J CANC, 92(8), 2001, pp. 880-885
86. Haga, S; Hinoshita, E; Ikezaki, K; Fukui, M; Scheffer, GL; Uchiumi, T; Kuwano, M
    Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    S. Haga et al., "Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma", JPN J CANC, 92(2), 2001, pp. 211-219
87. Huang, RC; Liu, YG; Lin, Y; Fan, Y; Boynton, A; Yang, DZ; Huang, RP
    Enhanced apoptosis under low serum conditions in human glioblastoma cells by connexin 43 (Cx43)
    MOLECULAR CARCINOGENESIS
    
    R.C. Huang et al., "Enhanced apoptosis under low serum conditions in human glioblastoma cells by connexin 43 (Cx43)", MOL CARCINO, 32(3), 2001, pp. 128-138
88. Chabannes, E; Fauconnet, S; Bernardini, S; Wallerand, H; Adessi, GL; Bittard, H
    Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells
    CELLULAR SIGNALLING
    
    E. Chabannes et al., "Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells", CELL SIGNAL, 13(8), 2001, pp. 585-591
89. Fischer, U; Hemmer, D; Heckel, D; Michel, A; Feiden, W; Steudel, WI; Hulsebos, T; Meese, E
    KUB3 amplification and overexpression in human gliomas
    GLIA
    
    U. Fischer et al., "KUB3 amplification and overexpression in human gliomas", GLIA, 36(1), 2001, pp. 1-10
90. Abounader, R; Lal, B; Luddy, C; Koe, G; Davidson, B; Rosen, EM; Laterra, J
    In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis
    FASEB JOURNAL
    
    R. Abounader et al., "In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis", FASEB J, 15(13), 2001, pp. NIL_22-NIL_37
91. Maher, EA; Furnari, FB; Bachoo, RM; Rowitch, DH; Louis, DM; Cavenee, WK; DePinho, RA
    Malignant glioma: genetics and biology of a grave matter
    GENES & DEVELOPMENT
    
    E.A. Maher et al., "Malignant glioma: genetics and biology of a grave matter", GENE DEV, 15(11), 2001, pp. 1311-1333
92. Matthews, PM; Wylezinska, M; Cadoux-Hudson, T
    Novel approaches to imaging brain tumors
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    
    P.M. Matthews et al., "Novel approaches to imaging brain tumors", HEMAT ONCOL, 15(4), 2001, pp. 609
93. Nafe, R; Glienke, W; Schlote, W; Schneider, B
    EGFR gene amplification in glioblastomas - Is there a relationship with morphology of tumor cell nuclei and proliferative activity?
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    
    R. Nafe et al., "EGFR gene amplification in glioblastomas - Is there a relationship with morphology of tumor cell nuclei and proliferative activity?", ANAL QUAN C, 23(2), 2001, pp. 135-143
94. Peschanski, M
    Cell and gene therapies to the brain: three predictable failures
    M S-MEDECINE SCIENCES
    
    M. Peschanski, "Cell and gene therapies to the brain: three predictable failures", M S-MED SCI, 17(6-7), 2001, pp. 804-806
95. Andrews, DW; Resnicoff, M; Flanders, AE; Kenyon, L; Curtis, M; Merli, G; Baserga, R; Iliakis, G; Aiken, RD
    Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas
    JOURNAL OF CLINICAL ONCOLOGY
    
    D.W. Andrews et al., "Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas", J CL ONCOL, 19(8), 2001, pp. 2189-2200
96. Grossman, SA; Phuphanich, S; Lesser, G; Rozental, J; Grochow, LB; Fisher, J; Piantadosi, S
    Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high-grade gliomas
    JOURNAL OF CLINICAL ONCOLOGY
    
    S.A. Grossman et al., "Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high-grade gliomas", J CL ONCOL, 19(13), 2001, pp. 3260-3266
97. Del Bufalo, D; Trisciuoglio, D; Biroccio, A; Marcocci, L; Buglioni, S; Candiloro, A; Scarsella, M; Leonetti, C; Zupi, G
    Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    D. Del Bufalo et al., "Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity", J CELL BIOC, 83(3), 2001, pp. 473-483
98. Wyatt-Ashmead, J; Kleinschmidt-DeMasters, BK; Hill, DA; Mierau, GW; McGavran, L; Thompson, SJ; Foreman, NK
    Rhabdoid glioblastoma
    CLINICAL NEUROPATHOLOGY
    
    J. Wyatt-Ashmead et al., "Rhabdoid glioblastoma", CLIN NEUR, 20(6), 2001, pp. 248-255
99. Wharton, SB; Whittle, IR; Collie, DA; Bell, HS; Ironside, JW
    Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis
    CLINICAL NEUROPATHOLOGY
    
    S.B. Wharton et al., "Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis", CLIN NEUR, 20(5), 2001, pp. 212-218
100. Sasaki, A; Yoshida, T; Kurihara, H; Sasaki, T; Nakazato, Y
     Glioblastoma with large numbers of eosinophilic hyaline droplets in neoplastic astrocytes
     CLINICAL NEUROPATHOLOGY
     
     A. Sasaki et al., "Glioblastoma with large numbers of eosinophilic hyaline droplets in neoplastic astrocytes", CLIN NEUR, 20(4), 2001, pp. 156-162